Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $470.55 | 17 | 69.5% |
| Education | $206.21 | 3 | 30.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $389.53 | 12 | $0 (2020) |
| Ferring Pharmaceuticals Inc. | $237.68 | 5 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $19.40 | 1 | $0 (2019) |
| Mission Pharmacal Company | $18.40 | 1 | $0 (2019) |
| Ferring International Pharmascience Center US | $11.75 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $79.14 | 4 | AbbVie Inc. ($79.14) |
| 2019 | $361.40 | 7 | Ferring Pharmaceuticals Inc. ($194.46) |
| 2018 | $204.48 | 7 | AbbVie, Inc. ($181.25) |
| 2017 | $31.74 | 2 | Ferring Pharmaceuticals Inc. ($31.74) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2020 | AbbVie Inc. | ORIAHNN (Drug), ORILISSA | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: WOMENS HEALTH | ||||||
| 10/28/2020 | AbbVie Inc. | ORIAHNN (Drug), ORILISSA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: WOMENS HEALTH | ||||||
| 10/10/2020 | AbbVie Inc. | ORIAHNN (Drug), ORILISSA | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: WOMENS HEALTH | ||||||
| 06/10/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: WOMENS HEALTH | ||||||
| 08/30/2019 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Education | In-kind items and services | $97.23 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 07/22/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Endocrinology | ||||||
| 06/25/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $99.82 | General |
| Category: Endocrinology | ||||||
| 06/20/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Endocrinology | ||||||
| 06/13/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $19.40 | General |
| 06/03/2019 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Education | In-kind items and services | $97.23 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 03/08/2019 | Mission Pharmacal Company | CitraNatal (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Prenatal Vitamin & Mineral | ||||||
| 12/13/2018 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 12/12/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $113.87 | General |
| Category: Endocrinology | ||||||
| 12/04/2018 | Ferring International Pharmascience Center US | — | Education | In-kind items and services | $11.75 | General |
| 11/27/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Endocrinology | ||||||
| 10/30/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Endocrinology | ||||||
| 09/05/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Endocrinology | ||||||
| 08/21/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Endocrinology | ||||||
| 05/30/2017 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
| 02/27/2017 | Ferring Pharmaceuticals Inc. | MENOPUR (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: REPRODUCTIVE HEALTH | ||||||
About Dr. Reshef Tal, M.D
Dr. Reshef Tal, M.D is a Reproductive Endocrinology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982916698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reshef Tal, M.D has received a total of $676.76 in payments from pharmaceutical and medical device companies, with $79.14 received in 2020. These payments were reported across 20 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($470.55).
Practice Information
- Specialty Reproductive Endocrinology
- Location New Haven, CT
- Active Since 07/10/2010
- Last Updated 08/26/2014
- Taxonomy Code 207VE0102X
- Entity Type Individual
- NPI Number 1982916698
Products in Payments
- MENOPUR (Drug) $237.68
- Orilissa (Drug) $196.52
- Lupron (Drug) $113.87
- ORIAHNN (Drug) $57.13
- ORILISSA (Drug) $22.01
- CitraNatal (Drug) $18.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Reproductive Endocrinology Doctors in New Haven
Sandra Carson, Md, MD
Reproductive Endocrinology — Payments: $224,238
Lubna Pal, Md, MD
Reproductive Endocrinology — Payments: $24,206
Dr. David Frankfurter, Md, MD
Reproductive Endocrinology — Payments: $17,717
Asima Ahmad, Md, Mph, MD, MPH
Reproductive Endocrinology — Payments: $2,313
Aydin Arici, Md, MD
Reproductive Endocrinology — Payments: $539.96
Liubin Yang
Reproductive Endocrinology — Payments: $188.85